Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.78 -0.69 (-1.84%)
As of: Aug 20, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Net Income Growth (3y) (2012 - 2026)

Teva Pharmaceutical Industries (TEVA) Net Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 14.04%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -0.23%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -27.09%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 8.71%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -34.81%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 14.78%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 36.74%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn -86.97%

Historic Data

Download Data
DateValue
Jun 30, 2026 14.04%
Mar 31, 2026 51.28%
Dec 31, 2025 32.99%
Sep 30, 2025 88.99%
Jun 30, 2025 44.40%
Mar 31, 2025 30.57%
Dec 31, 2024 -22.12%
Sep 30, 2024 -48.64%
Jun 30, 2024 -83.43%
Mar 31, 2024 84.98%
Dec 31, 2023 -137.33%
Sep 30, 2023 26.35%
Jun 30, 2023 -167.37%
Mar 31, 2023 -127.22%
Dec 31, 2022 -165.31%
Sep 30, 2022 30.28%
Jun 30, 2022 25.45%
Mar 31, 2022 -118.71%
Dec 31, 2021 64.04%
Sep 30, 2021 53.78%